Novavax, Inc. (NASDAQ: NVAX) Seen Running Too Hot, Let’s Look At This More Closely

Currently, there are 139.51M common shares owned by the public and among those 133.41M shares have been available to trade. The company’s stock has a 5-day price change of 6.47% and 17.30% over the past three months. NVAX shares are trading -3.96% year to date (YTD), with the 12-month market performance down to -40.21% lower. […]

Growth Story Still Intact For Novavax, Inc. (NVAX)

Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $4.67, with 5.41 million shares of worth about $25.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.37% during that period and on May 01, 2024 the price saw a gain […]

Novavax, Inc. (NASDAQ: NVAX) Stock In Prove Me State

Novavax, Inc. (NVAX) concluded trading on Thursday at a closing price of $3.95, with 3.36 million shares of worth about $13.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -36.80% during that period and on April 25, 2024 the price saw a loss […]

Novavax, Inc. (NASDAQ: NVAX): Do Not Miss The Gain Train

Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $3.89, with 3.71 million shares of worth about $14.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.33% during that period and on April 17, 2024 the price saw a loss […]

Is Novavax, Inc. (NASDAQ: NVAX) Proving The Doubters Wrong?

Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $4.26, with 5.29 million shares of worth about $22.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.67% during that period and on April 10, 2024 the price saw a loss […]

Reviewing The Case For Novavax, Inc. (NVAX) Going Higher

Currently, there are 139.51M common shares owned by the public and among those 131.81M shares have been available to trade. The company’s stock has a 5-day price change of -5.82% and -5.62% over the past three months. NVAX shares are trading -5.62% year to date (YTD), with the 12-month market performance down to -31.26% lower. […]

These Numbers Could Change Investor Views For Novavax, Inc. (NASDAQ: NVAX)

Currently, there are 139.51M common shares owned by the public and among those 131.81M shares have been available to trade. The company’s stock has a 5-day price change of -4.66% and -6.92% over the past three months. NVAX shares are trading -1.88% year to date (YTD), with the 12-month market performance down to -22.02% lower. […]

There Is Clear Momentum For Novavax, Inc. (NASDAQ: NVAX)

Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $4.83, with 9.16 million shares of worth about $44.27 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.11% during that period and on March 20, 2024 the price saw a loss […]

Novavax, Inc. (NVAX) Testing Investors’ Patience Right Now

Currently, there are 139.51M common shares owned by the public and among those 131.86M shares have been available to trade. The company’s stock has a 5-day price change of -6.56% and -7.23% over the past three months. NVAX shares are trading 6.87% year to date (YTD), with the 12-month market performance down to -21.92% lower. […]

Do Novavax, Inc. (NASDAQ: NVAX) Fit In A Value Investing Philosophy?

Currently, there are 139.51M common shares owned by the public and among those 131.87M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]